Clinical Trial Update: A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating irinotecan in combination with BKM-120 in previously treated advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BKM-120 (buparlisib) (buparlisib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED